Clinicians and researchers have recognized a disturbing trend in recent years: colorectal cancer (CRC) in young people is skyrocketing. In individuals under the age of 50, the incidence of CRC has increased about 2% each year since the 1990s, and, according to the American Cancer Society, is now the leading cause of death in males … Read more
Andrew Ciardelli’s annual brothers’ hunting trip in Idaho took a turn for the worse when the stomach issues he had lived with for years suddenly became unbearable. Years before the trip, a urologist told Ciardelli that the cause of his pain and the blood in his stool was hemorrhoids. “They told me as long as … Read more
In trial after clinical trial, metastatic colorectal cancer has been largely undeterred by immune checkpoint inhibitors. Although these drugs have shown effectiveness in Hodgkin lymphoma, lung cancer, bladder cancer, kidney cancer, and nearly a dozen other malignancies, their track record against colorectal cancer has been lackluster, particularly for patients with the most common subtype of … Read more
Simone Ledward-Boseman has many roles: She’s a writer, artist, and singer. And for some time, she was a caregiver to her late husband, Chadwick Boseman, the actor known for playing Black Panther and groundbreaking figures like James Brown and Jackie Robinson. These days, Ledward-Boseman has added more titles to her list: activist and advocate. “I’m … Read more
Dana-Farber researchers have found that a transcription factor called SOX17 gives colon cancer a safe space to develop.
Stories of young adults being diagnosed with colorectal cancer are becoming more common as the rates continue to rise among adults between 20 and 49.
Colon and rectal cancer combined are the fourth most commonly diagnosed cancers. Eighty percent of patients are diagnosed at a stage of disease when treatment is given with curative-intent. However, treatment can have both short- and long-term side effects that may impact quality of life. To address these concerns, investigators at Dana-Farber have led clinical … Read more
Two weeks after turning 50, Wendy Tamis Robbins learned she had stage II colon cancer. Having lived with anxiety, obsessive compulsive disorder, and panic disorders nearly all her life, she used the same strategies that helped her navigate these struggles to meet her cancer diagnosis head-on. Robbins handled the ups and downs of her summer … Read more
Although hemorrhoids and colon cancer share certain symptoms, such as rectal bleeding, they are very different conditions. People who experience symptoms of either should get evaluated by a physician: while hemorrhoids are far more common than colon cancer, an exam is necessary to determine which one, if either, a patient has and how it should … Read more
For close to a year, Melanie Spears had been experiencing abdominal pain and constipation. As an Army veteran who had served in Afghanistan, she was used to pushing through adversity — so she tweaked her diet and dealt with what doctors diagnosed as irritable bowel syndrome. Only after microscopic blood samples in her stool led … Read more
Researchers in the late 1970s wanted to address challenges with a chemotherapy drug called floxuridine. It’s a form of chemotherapy invented in the 1950s that turns into its active form, 5-fluorouracil, or 5-FU, when metabolized. One challenge is that 5-FU has off-target effects, meaning it can damage healthy organs when given throughout the body. In … Read more
As a pediatric pharmacist located in Dana-Farber’s Jimmy Fund Clinic, Patrick never tires of seeing smiling, young cancer patients enjoying the clinic’s playroom. The resilience they display throughout infusions, blood draws, and other procedures not only inspires him, but it also serves as a source of resolve he carries into his ongoing cancer care. Patrick, … Read more
The team representing Dana-Farber’s Young-Onset Colorectal Cancer Center called Team Beyond CRC (colorectal cancer) is looking forward to the fast-approaching Boston Marathon® Jimmy Fund Walk presented by Hyundai taking place on Sunday, October 2. Team Beyond CRC will be among 90 other employee-led teams participating in the Jimmy Fund Walk. This longtime annual event brings … Read more
At 43, Erick Eigner was leading a healthy and fulfilling life: spending time with family, working in marketing at Microsoft, and hitting the gym six days a week. Cancer was the last thing he was thinking about when he went to the doctor for a physical and mentioned some concerns he had about swallowing. The … Read more
At 28 years old, Dana-Farber bioinformatics analyst Carino Gurjao is already making a splash in the field of colorectal cancer research. He is coming off the back of a big year: The Paris-born researcher was named to Forbes Healthcare’s 2022 30 Under 30 list for his role in the Giannakis Lab at Dana-Farber, which identified … Read more
Cancer is a disease that’s often associated with older people; however, a growing number of younger patients are being diagnosed with colorectal cancer. Since the 1990s, the rate of colorectal cancer diagnoses has more than doubled in adults age 20 to 49. Alexa Morell is one of these patients. She didn’t expect her diagnosis: metastatic … Read more
When Michael Voisine went to the doctor in 2017, he had just one symptom: a burning sensation on his skin, right around the corner of his stomach. After a CAT scan, he was rushed into the operating room for an emergency appendectomy. But doctors found more than just an inflamed appendix: They also discovered an … Read more
Until recently, health authorities recommended that most individuals have their first colonoscopy at age 50 to screen for colorectal cancer or precancerous growths, which can often be removed to prevent cancer development. But a worrying rise in colorectal cancer in younger people in recent years has prompted a federal task force to recommend the initial … Read more
Jonathan Owens says he was fortunate to get a second chance at life. By spreading the word, he hopes others won’t need similar luck. Owens had the same primary care physician for nearly 20 years, and was diligent about keeping himself in shape, as he reached his 50th birthday. Like many of his similarly aged … Read more
Khiem Tran’s response to drug therapy for advanced colorectal cancer seemed to defy the severity of his disease. After just a few doses of chemotherapy and a targeted drug, the cancer, which had spread from his rectum to his liver, was in full retreat, with a key marker of tumor burden dropping from stratospheric levels … Read more